¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"density gradient"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • population density
    Àα¸¹Ðµµ
  • proton density contrast
    ¾ç¼ºÀڹеµ´ëÁ¶
  • proton density weighted image
    ¾ç¼ºÀڹеµ°­Á¶¿µ»ó
  • spin density
    ½ºÇɹеµ
  • spin density weighted image
    ½ºÇɹеµ°­Á¶¿µ»ó
  • shadow density
    ±×¸²ÀÚÀ½¿µ, Åõ¿µÀ½¿µ
  • very low density lipoprotein
    ÃÊÀú¹ÐµµÁöÁú´Ü¹éÁú
  • axial gradient
    üÃà±â¿ï±â, üÃà°æ»ç
  • active gradient shielding
    ´Éµ¿°æ»çÂ÷Æó
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£»ê¼ÒºÐ¾ÐÂ÷
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • background gradient
    ¹è°æ±â¿ï±â
  • bipolar gradient
    ¾ç±Ø±â¿ï±â, µÎ±Ø±â¿ï±â
  • bipolar velocity encoding gradient
    ¾ç±Ø¼ÓµµºÎȣȭ°æ»ç, µÎ±Ø¼ÓµµºÎȣȭ±â¿ï±â
  • constant gradient
    °íÁ¤±â¿ï±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • reticular density
    ¸Á»óÀ½¿µ, ±×¹°À½¿µ
  • shadow density
    À½¿µ¹Ðµµ
  • spin density
    ½ºÇɹеµ
  • high-density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹é
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹é
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • spin density weighted image
    ½ºÇɹеµ°­Á¶¿µ»ó
  • active gradient shielding
    ´Éµ¿±â¿ï±âÂ÷Æó, ´Éµ¿°æ»çÂ÷Æó
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£»ê¼ÒºÐ¾ÐÂ÷
  • axial gradient
    üÃà±â¿ï±â, üÃà°æ»ç
  • gradient refocused acquisition
    ±â¿ï±âÀçÃÊÁ¡È¹µæ
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • background gradient
    ¹è°æ±â¿ï±â
  • bipolar gradient
    ¾ç±Ø±â¿ï±â, µÎ±Ø±â¿ï±â
  • bipolar velocity encoding gradient
    ¾ç±Ø¼ÓµµºÎȣȭ±â¿ï±â, µÎ±Ø¼ÓµµºÎȣȭ±â¿ï±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷
  • frequency encoding gradient
    Á֯ļö ºÎȣȭ °æ»ç
  • gradient induced phase shift effect
    °æ»ç À¯µµ À§»ó º¯À§ È¿°ú
  • gradient limiting reabsorption
    ³óµµÁõ°¨Á¦ ÇѼº ÀçÈí¼ö.
  • gradient magnetic coil
    °æ»ç ÀÚ±â ÄÚÀÏ
  • gradient magnetic field
    °æ»ç ÀÚ±âÀå
  • gradient method
    °è´ÜÀû°Ë»ç¹ý
  • gradient moment
    °æ»ç ¸ð¸àÆ®
  • gradient moment nulling (GMN)
    °æ»ç ¸ð¸àÆ® ¹«È¿È­
  • gradient motion rephasing (GMR)
    °æ»ç ¿îµ¿ ÀçÀ§»ó
  • gradient recalled echo
    °æ»ç ȸº¹ ¿¡ÄÚ
  • gradient refocused acquisition
    °æ»ç ÀçÃÊÁ¡ ȹµæ
  • gradient refocused imaging
    °æ»ç ÀçÃÊÁ¡ ¿µ»ó
  • gradient shielding
    °æ»ç Â÷Æó
  • gradient slope
    °æ»ç ±â¿ï±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • linear density
    ¼±»óÀ½¿µ
  • lipoprotein,low-density
    Àú¹Ðµµ(î¸ÚËÓø)
  • lipoprotein,very-low-density
    ÃÊÀúºñÁß(õ±î¸Ýïñì)
  • low density lipoprotein
    Àú¹ÐµµÁö´Ü¹é
  • low density lipoprotein =LDL
    Àú¹ÐµµÁö´Ü¹é.
  • low density lipoprotein =LDL
    Àú¹ÐµµÁö´Ü¹éÁú.
  • low electron density
    ÀúÀüÀڹеµ(î¸ï³í­ ÚËöô).
  • magnetic flux density
    ÀÚ±â À¯µ¿ ¹Ðµµ
  • middle density
    Áß°£ À½¿µ, Áß°£ ¹Ðµµ
  • minimum useful density
    ÃÖ¼ÒÀ¯È¿³óµµ(õÌá³êóüùÒØöô).
  • mosquito density
    ¸ð±â¹Ðµµ.
  • neutral density filter
    Áß¼ºÇÊÅÍ
  • neutron flux density
    Áß¼ºÀڼӹеµ
  • nodular density
    °áÀý¼º À½¿µ
  • optical density
    ±¤Çйеµ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gradient layer
    ±¸¹èÃþ(ÎþÛÕöµ)
  • gradient mixer
    ±¸¹è È¥ÇÕ±â(ÎþÛÕûèùêÐï)
  • gradient plate technique
    ±¸¹è ÆÇ(ÎþÛÕ÷ù)¼ú(âú)
  • gradient sievorptive chromatography
    ±¸¹è ¿©°úÈíÂø(ÎþÛÕÕëΦýåó·) Å©·Î¸¶Åä±×·¡ÇÇ
  • isokinetic gradient
    µî¿ªÇÐ ±¸¹è(ÔõÕôùÊÎøÛÎ)
  • isopycnic gradient centrifugation
    µî¹Ðµµ±¸¹è¿ø½ÉºÐ¸®(ÔõÚËÓøÎøÛÎêÀãýÝÂ×î)
  • pH gradient electrophoresis
    pH ±¸¹è Àü±â¿µµ¿(ÎþÛÕï³Ñ¨ç¶ÔÑ)
  • potential gradient
    "ÀüÀ§ ±¸¹è(ï³êÈÎþÛÕ), ÆÛÅÙ¼È ±¸¹è(ÎþÛÕ)"
  • preformed gradient isodensity centrifugation
    ±âÇü¼º ±¸¹è(Ðþû¡à÷ÎþÛÕ) ¾ÆÀ̼ҹеµ ¿ø½ÉºÐ¸®(ÚËÓøêÀãýÝÂ×î)
  • proton gradient
    ¾ç¼ºÀÚ ±â¿ï±â
  • receptor gradient
    ¼ö¿ëü ±¸¹è(áôé»ô÷ÎþÛÕ)
  • shear gradient
    ½¬¾î ±¸¹è(ÎøÛÎ)
  • sucrose gradient centrifugation
    ½´Å©·Î½º ±¸¹è ¿ø½ÉºÐ¸®(ÎøÛÎêÀãýÝÂ×î)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • diffusion gradient pulse
    È®»ê°æ»çÆÞ½º
  • fast gradient recalled echo method
    °í¼Ó°æ»çȸº¹¿¡ÄÚ±â¹ý
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó´Ù¸éȸ¼Õ°æ»çȸº¹¿¬¼â
  • field gradient
    ÀÚÀå°æ»ç
  • flow compensation gradient technique
    À¯µ¿º¸»ó°æ»ç±â¹ý
  • flow sensitive gradient echo sequence
    À¯µ¿¹Î°¨°æ»ç¿¡ÄÚ¿¬¼â
  • frequency encoding gradient
    Á֯ļöºÎȣȭ°æ»ç
  • gradient
    °æ»ç
  • gradient acquisition imaging
    °æ»çȹµæ¿µ»ó
  • gradient coil
    °æ»çÄÚÀÏ
  • gradient echo [=GRE]
    °æ»ç¿¡ÄÚ
  • gradient echo [=GRE] imaging
    °æ»ç¿¡ÄÚ¿µ»ó
  • gradient echo [=GRE] pulse sequence
    °æ»ç¿¡ÄÚÆÞ½º¿¬¼â
  • gradient echo effect
    °æ»ç¿¡ÄÚÈ¿°ú
  • gradient echo sequence
    °æ»ç¿¡ÄÚ¿¬¼â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
GGE generalized glandular enlargement; gradient gel electrophoresis
GMN gradient moment nulling
GMR gallops, murmurs, rubs; gradient motion rephasing
grad gradient; gradually; graduate
GRASS gradient recalled acquisition in a steady state
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MP-RAGE Magnetization Prepared RApid Gradient Echo
NEPHGE Nonequilibrium pH gradient electrophoresis
PCR-DGGE Polymerase chain reaction-denaturing gradient gel electrophoresis
PFG Pulse field gradient
PGSE Pulsed Gradient Spin Echo
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • magnetic flux density
    ÀÚ±â À¯µ¿ ¹Ðµµ
  • minimum useful density
    ÃÖ¼Ò À¯È¿ ³óµµ
  • mosquito density
    ¸ð±â ¹Ðµµ
  • nodular density
    °áÀý¼º À½¿µ
  • perihilar density
    Æó¹® ÁÖÀ§ À½¿µ
  • photographic density
    »çÁø ÈæÈ­µµ
  • pixel density
    Çȼ¿ À½¿µ, È­¼Ò À½¿µ
  • power density
    Ãâ·Â ¹Ðµµ
    ÀÏÁ¤ Ç¥¸é¿¡ ´ëÇÑ ·¹ÀÌÀú Ãâ·ÂÀÇ ºÐÆ÷ ÃøÁ¤. Ãâ·Â ¹Ðµµ¸¦ À§ÇÑ ´ÜÀ§´Â ÀüÇüÀûÀ¸·Î ÀÏÁ¤ Ç¥¸é ȤÀº ÃÊÁ¡ Å©±â¿¡ ´ëÇÑ 1cm
  • proton density contrast
    ¾çÀÚ ¹Ðµµ ´ëÁ¶
  • proton density weighting
    ¾çÀÚ °­Á¶
  • proton spin density
    ¾çÀÚ ¹Ðµµ
  • reticular density
    ¸Á»ó À½¿µ
  • spin density weighted image
    ½ºÇÉ ¹Ðµµ °­Á¶ ¿µ»ó
  • vapo density
    Áõ±â ¹Ðµµ
  • very low density lipoprotein
    ÃÊÀú ºñÁß Áö´Ü¹é, ÃÊÀú ºñÁß ÁöÁú ´Ü¹é, ÃÊÀú ºñÁß Áö´Ü¹éÁú, ÃÊÀú ºñÁß ÁöÁú ´Ü¹éÁú, ÃÊÀúºñÁß Áö¹æ ´Ü¹é
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
neutral-density filter <equipment> A light-absorbing filter whose absorption spectrum is moderately flat. Depending on the type, the absorption curve is flat primarily in the visible spectral range, or may extend to varying degrees beyond the visible range. For video microscopy, this is an important point since the absorbance may or may not extend into the near-infrared region where the sensitivity of many video image pickup devices is very high.
(05 Aug 1998)
density 1. <radiology> The amount of darkness or light in an area of a scan reflects the compactness and density of tissue. Differences in tissue density are the basis for CT and MR scans.
2. <microscopy> Logarithm to the base 10 of the reciprocal of transmittance.
(12 Jan 1998)
density-dependent <epidemiology> 1. Effects whose intensity changes with increasing population density.
2. Effects whose intensity increases with increasing population density, for example a mortality which becomes very high near a carrying capacity. Effects which become less pronounced at higher population sizes (perhaps the reduction in fecundity caused by the difficulty of mating) are sometimes called inverse density dependent. Density dependent effects are often a cause of nonlinearity in a model.
(05 Dec 1998)
density dependent inhibition of growth <cell culture> The phenomenon exhibited by most normal (anchorage dependent) animal cells in culture that stop dividing once a critical cell density is reached.
The critical density is considerably higher for most cells than the density at which a monolayer is formed, for this reason, most cell behaviourists prefer the term density dependent inhibition of growth as this avoids any confusion with contact inhibition of locomotion, a totally different phenomenon that is contact dependent.
(12 Jan 1998)
incidence density The person-time incidence rate.
(05 Mar 2000)
intermediate density lipoprotein Class of lipoproteins formed in degradation of very-low-density lipoproteins; about half are cleared quickly from the plasma into the liver by receptor-mediated endocytosis; the other half are degraded into low density lipoproteins.
(05 Mar 2000)
inverse density dependence <epidemiology> See density dependence.
(05 Dec 1998)
optical density 1. <chemistry, investigation> Absorbance is defined as a logarithmic function of the percent transmission of a wavelength of light through a liquid.
2. <microbiology> This can be used as a measure of the amount of light absorbed by a suspension of bacterial cells or a solution of an organic molecule, it is measured by a colourimeter or spectrophotometer.
Absorbance values are used to plot the growth of bacteria in suspension cultures and to gauge the purity and concentration of molecules (such as proteins) in solution.
See: absorption.
(15 Jan 1998)
organismal density <microbiology> Number of organisms or items per unit area or volume.
(09 Oct 1997)
either particle flux density The particle fluence rate, or energy flux density, the energy fluence rate of intensity.
Compare: fluence.
(05 Mar 2000)
familial high density lipoprotein deficiency Familial high {density lipoprotein deficiency}; a heritable disorder of lipid metabolism characterised by almost complete absence from plasma of high density lipoproteins, and by storage of cholesterol esters in foam cells, tonsillar enlargement, an orange or yellow-gray colour of the pharyngeal and rectal mucosa, hepatosplenomegaly, lymph node enlargement, corneal opacity, and peripheral neuropathy; autosomal recessive inheritance.
Synonym: familial high {density lipoprotein deficiency}, Tangier disease.
Origin: G. An-, priv., + alpha, a, + lipoprotein + -aemia, blood
(05 Mar 2000)
flux density <radiobiology> Total amount of a quantity passing through a unit surface area in unit time
See: flux.
(09 Oct 1997)
low density lipoprotein <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats in the bloodstream.
High levels of low density lipoprotein are considered a positive risk factor for the development of coronary artery disease. Less than 130 mg/dl is desirable, 130 to 159 mg/dl is borderline high, over 160 is considered high.
Acronym: LDL
(10 Jan 1998)
low density lipoprotein receptor <biochemistry> A cell surface protein that mediates the endocytosis of low density lipoprotein by cells.
Genetic defects in low density lipoprotein receptors lead to abnormal serum levels of low density lipoprotein and hypercholesterolaemia.
(16 Mar 1998)
low-density lipoprotein receptors Receptors on the surface of cells, especially liver cells, which bind to low density lipoprotein and promote clearance of LDL from the plasma.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á